CEO SUMMARY: Taken collectively, the growing number of federal investigations of clinical lab companies and health insurer lawsuits against lab companies alleging fraudulent business practices signals a disturbing new trend for the lab industry. Although these allegations are leveled at just a handful of lab companies, the amount of money these labs took out of the system exceeds a billion dollars. Some experts expect payers will enact tough requirements to stop such abuses.
Is New Cycle of Fraud Plaguing Lab Industry?
Sins of a few labs may cause unnecessary pain for all clinical labs and pathology groups
- By Robert Michel
- > From the Volume XXII No. 12 - August 24, 2015 Issue
- Tags: billing medicare, breast cancer test, breast cancer testing, cancer testing, cigna audit, clinical lab, Clinical Laboratory, clinical laboratory industry, clinical laboratory test, clinical laboratory testing, compliance laws, dark report, diagnostic assays, diagnostic lab, diagnostic laboratories, diagnostic laboratory, diagnostic laboratory services, genetic test, genetic testing, genetic testing lab, genetic testing labs, genetic tests, lab administrator, lab industry, lab management, lab manager, lab managers, lab test, lab tests, laboratories, laboratory companies, laboratory industry, laboratory service, laboratory services, laboratory test, laboratory testing, Medicare, molecular diagnostic, molecular diagnostic assays, pathologists, the dark report
